Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

56.00 -0.19 (-0.34%)
Streaming Delayed Price Updated: 1:12 PM EDT, Jun 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Catalent Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
As cases of the monkeypox virus continue to grow, the race is on for a way to fight this once-rare disease.  Since the first reports of monkeypox infection in the United States started popping up in... 
Via Benzinga
Despite Price Cut, RBC Capital Is Bullish On Catalent's Long Term Targets
Via Benzinga
Expert Ratings for Catalent
Catalent (NYSE:CTLT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where Catalent Stands With Analysts
Within the last quarter, Catalent (NYSE:CTLT) has observed the following analyst ratings: 
Via Benzinga
Catalent Reports Mixed Q4 Earnings; FY23 Sales Expectation Lags Consensus
Via Benzinga
Recap: Catalent Q4 Earnings
  Catalent (NYSE:CTLT) reported its Q4 earnings results on Monday, August 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Catalent Faces Several Price Target Cuts By Analysts After Q4 Results
Catalent, Inc. (NYSE: CTLT) reported mixed results for its fourth quarter on Monday. For FY23, Catalent said it expects $4.975-$5.225 billion in revenue compared to the consensus of $5.26 billion.... 
Via Benzinga
HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock
HC Wainwright & Co. raised the price target for Rockwell Medical, Inc. (NASDAQ: RMTI) from $3 to $8. Rockwell Medical shares rose 0.7% to close at $1.42 on Monday. 
Via Benzinga
Catalent To $115? Here Are 5 Other Price Target Changes For Tuesday
Barclays cut the price target on Catalent, Inc. (NYSE: CTLT) from $130 to $115. Barclays analyst Luke Sergott maintained an Overweight rating on the stock. Catalent shares fell 7.4% to close at $92.28... 
Via Benzinga
Catalent, Tellurian And Other Big Losers From Monday
U.S. stocks closed lower with the Dow Jones dropping around 185 points on Monday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says
Via Benzinga
Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report
Via Benzinga
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Gainers 
Via Benzinga
S&P 500 Stock Market Winners Today
Diamondback Energy was the index's top performer Monday. 
Via Investor's Business Daily
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ. 
Via Benzinga
Global Markets Lower On Worries Other Central Banks Will Follow The Fed
(Monday Market Open) Equity index futures are pointing to a lower open as investors are still reeling after Friday’s tough talk from Federal Reserve Chairman Jerome Powell. 
Via Benzinga
Why Catalent Stock Is Trading Lower Today
Catalent Inc (NYSE: CTLT) shares are trading lower Monday after the company reported mixed results and said it expects 2023 revenue to be lower than analysts anticipated. 
Via Benzinga
US Futures Paint Gloomy Outlook For Fresh Trading Week As Data-Dependence Introduces Caution Ahead Of Key Main Street Readings, Fed Speeches
The major U.S. index futures are notably lower on Monday, signaling that stocks may be carrying over the downward momentum from Friday. 
Via Benzinga
Fear & Greed Index Moves To 'Fear' Zone As Dow Dips Over 1,000 Points Following Powell's Speech
The CNN Money Fear and Greed index moved to the "fear" zone after the Dow Jones dipped more than 1,000 points on Friday following Powell’s comments. Fed Chair Jerome Powell, at the Jackson Hole... 
Via Benzinga
Dow, Nasdaq Futures Lower Following Friday's Sell-Off; US Dollar Surges To 20-Year High
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 1,000 points in the previous session following speech from Federal Reserve Chairman... 
Via Benzinga
Earnings Scheduled For August 29, 2022
Companies Reporting Before The Bell • NAPCO Security (NASDAQ:NSSC) is expected to report earnings for its fourth quarter. 
Via Benzinga
Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Bitcoin Tumbles Below This Major Level Following Powell's Remarks; Here Are The Top Crypto Movers For Monday
Bitcoin (CRYPTO: BTC), the world’s most valued cryptocurrency, recorded a massive sell-off, with price for the cryptocurrency falling below the $20,000 level this morning following comments from US... 
Via Benzinga
Catalent's Earnings: A Preview
Catalent (NYSE:CTLT) is set to give its latest quarterly earnings report on Monday, 2022-08-29. Here's what investors need to know before the announcement. Analysts estimate that Catalent will report... 
Via Benzinga
Is Novavax Stock A Buy After Omicron Results Impress Two FDA Experts?
The FDA is reviewing additional manufacturing data before making a decision. 
Via Investor's Business Daily
Quant Ratings Updated on 75 Stocks
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace
Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know
Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours,... 
Via Benzinga
80 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.